GOG-212: A Randomised Phase III trial of maintenance chemotherapy comparing 12 monthly cycles of single agent Paclitaxel or CT-2103 (IND# 70177) versus no treatment until documented relapse in women with advanced ovarian, primary peritoneal or fallopian tube cancer who achieve a complete clinical response to primary platinum/taxane chemotherapy